| Mrs Amy Butenschoen Galdamez, MD | |
|
9501 Baptist Health Dr, Suite 770, Little Rock, AR 72205-6225 | |
| (501) 221-9700 | |
| (501) 221-3239 |
| Full Name | Mrs Amy Butenschoen Galdamez |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 9501 Baptist Health Dr, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134361827 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | E-7694 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Clinic For Women, P. A. | 9335143007 | 7 |
News Archive
FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Earlier this year, the National Association of Boards of Pharmacy® (NABP®) was introduced to the AWARxE campaign, which was created and implemented by the Minnesota Pharmacists Foundation in 2007. Moved by the power of the campaign, NABP obtained the AWARxE program so that its message could be shared on a national level.
"HIV organizations, researchers and activists have criticized the WHO and UNAIDS for not clearly communicating guidelines on HIV and hormonal contraception to African women, who remain the most affected by the continent's high HIV prevalence rates," PlusNews reports.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma fixation devices will continue to see rapid growth over the next five years despite the recent economic slowdown. MRG's US Markets for Trauma Devices 2010 report finds that this market will remain highly dynamic over the next five years, with competitors introducing specialized devices in previously underserved segments of the trauma fixation market, fueling market growth.
› Verified 5 days ago
| Entity Name | Central Clinic For Women, P. A. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922058213 PECOS PAC ID: 9335143007 Enrollment ID: O20060912000125 |
News Archive
FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Earlier this year, the National Association of Boards of Pharmacy® (NABP®) was introduced to the AWARxE campaign, which was created and implemented by the Minnesota Pharmacists Foundation in 2007. Moved by the power of the campaign, NABP obtained the AWARxE program so that its message could be shared on a national level.
"HIV organizations, researchers and activists have criticized the WHO and UNAIDS for not clearly communicating guidelines on HIV and hormonal contraception to African women, who remain the most affected by the continent's high HIV prevalence rates," PlusNews reports.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma fixation devices will continue to see rapid growth over the next five years despite the recent economic slowdown. MRG's US Markets for Trauma Devices 2010 report finds that this market will remain highly dynamic over the next five years, with competitors introducing specialized devices in previously underserved segments of the trauma fixation market, fueling market growth.
› Verified 5 days ago
| Entity Name | Little Rock Gynecology And Obstetrics Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124346739 PECOS PAC ID: 1951427731 Enrollment ID: O20100929001031 |
News Archive
FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Earlier this year, the National Association of Boards of Pharmacy® (NABP®) was introduced to the AWARxE campaign, which was created and implemented by the Minnesota Pharmacists Foundation in 2007. Moved by the power of the campaign, NABP obtained the AWARxE program so that its message could be shared on a national level.
"HIV organizations, researchers and activists have criticized the WHO and UNAIDS for not clearly communicating guidelines on HIV and hormonal contraception to African women, who remain the most affected by the continent's high HIV prevalence rates," PlusNews reports.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma fixation devices will continue to see rapid growth over the next five years despite the recent economic slowdown. MRG's US Markets for Trauma Devices 2010 report finds that this market will remain highly dynamic over the next five years, with competitors introducing specialized devices in previously underserved segments of the trauma fixation market, fueling market growth.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy Butenschoen Galdamez, MD 9501 Baptist Health Dr, Suite 770, Little Rock, AR 72205-6225 Ph: (501) 221-9700 | Mrs Amy Butenschoen Galdamez, MD 9501 Baptist Health Dr, Suite 770, Little Rock, AR 72205-6225 Ph: (501) 221-9700 |
News Archive
FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Earlier this year, the National Association of Boards of Pharmacy® (NABP®) was introduced to the AWARxE campaign, which was created and implemented by the Minnesota Pharmacists Foundation in 2007. Moved by the power of the campaign, NABP obtained the AWARxE program so that its message could be shared on a national level.
"HIV organizations, researchers and activists have criticized the WHO and UNAIDS for not clearly communicating guidelines on HIV and hormonal contraception to African women, who remain the most affected by the continent's high HIV prevalence rates," PlusNews reports.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma fixation devices will continue to see rapid growth over the next five years despite the recent economic slowdown. MRG's US Markets for Trauma Devices 2010 report finds that this market will remain highly dynamic over the next five years, with competitors introducing specialized devices in previously underserved segments of the trauma fixation market, fueling market growth.
› Verified 5 days ago
Dr. Francisco Batres, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9101 Kanis Rd, Suite 300, Little Rock, AR 72205 Phone: 501-801-1200 Fax: 501-801-1207 | |
Dr. Kristin K Zorn, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
David Hutchins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Kristen Taylor Bracy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9500 Baptist Health Dr Ste 100, Little Rock, AR 72205 Phone: 501-224-5500 Fax: 501-224-1166 | |
Dayna D Whitcombe, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6119 Midtown Ave, Little Rock, AR 72205 Phone: 501-296-1800 Fax: 501-296-1711 | |
Nafisa Dajani, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Jennifer Afton Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5 Saint Vincent Cir Ste 300, Little Rock, AR 72205 Phone: 501-552-8800 Fax: 501-552-5343 |